Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
106.49
73.97
51.13
43.73
62.25
207.86
22.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
106.49
73.97
51.13
43.73
62.25
207.86
22.13
Raw Material Cost
28.48
18.79
15.33
13.43
23.31
43.14
10.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.19
-0.80
0.33
-0.43
-0.41
0.56
-0.56
Employee Cost
14.60
5.42
4.89
3.50
2.64
3.71
2.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
15.30
8.37
7.48
5.55
5.52
19.14
2.72
Total Expenditure (Excl Depreciation)
58.20
31.78
28.03
22.04
31.06
66.55
15.19
Operating Profit (PBDIT) excl Other Income
48.29
42.19
23.10
21.69
31.19
141.31
6.94
Other Income
15.41
10.14
8.34
6.07
5.03
1.71
0.62
Operating Profit (PBDIT)
63.70
52.33
31.44
27.76
36.22
143.02
7.56
Interest
0.14
0.06
0.08
0.15
0.13
0.18
0.18
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
63.56
52.27
31.36
27.61
36.09
142.84
7.38
Depreciation
1.24
0.81
0.75
0.66
0.50
0.50
0.45
Profit Before Tax
62.32
51.46
30.60
26.95
35.59
142.32
6.93
Tax
12.20
11.80
7.30
6.20
8.21
35.72
1.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.12
39.66
23.31
20.74
27.37
106.60
5.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.12
39.66
23.31
20.74
27.37
106.60
5.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.33
-0.30
0.14
0.97
-1.71
-10.34
-0.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
49.03
39.17
23.86
19.74
24.05
91.42
4.78
Equity Capital
8.57
8.57
8.57
8.57
7.51
7.51
7.51
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
262.44
216.91
188.42
144.47
124.56
16.36
7.28
Diluted Earnings per share
26.19
15.75
9.94
9.0
8.74
26.2
2.31
Operating Profit Margin (Excl OI)
45.35%
57.04%
45.18%
49.6%
50.1%
67.98%
31.36%
Gross Profit Margin
59.69%
70.66%
61.33%
63.14%
57.98%
68.72%
33.35%
PAT Margin
47.07%
53.62%
45.59%
47.43%
43.97%
51.28%
24.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 43.96% vs 44.67% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 25.17% vs 64.17% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 14.46% vs 82.64% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 133.33% vs -25.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of 3B Blackbio With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
106.49
229.01
-122.52
-53.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
106.49
229.01
-122.52
-53.50%
Raw Material Cost
28.48
26.32
2.16
8.21%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.19
0.00
-0.19
Employee Cost
14.60
39.59
-24.99
-63.12%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
15.30
92.07
-76.77
-83.38%
Total Expenditure (Excl Depreciation)
58.20
157.98
-99.78
-63.16%
Operating Profit (PBDIT) excl Other Income
48.29
71.03
-22.74
-32.01%
Other Income
15.41
2.38
13.03
547.48%
Operating Profit (PBDIT)
63.70
73.41
-9.71
-13.23%
Interest
0.14
8.64
-8.50
-98.38%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
63.56
64.77
-1.21
-1.87%
Depreciation
1.24
30.19
-28.95
-95.89%
Profit Before Tax
62.32
34.58
27.74
80.22%
Tax
12.20
9.33
2.87
30.76%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
50.12
25.24
24.88
98.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
50.12
25.24
24.88
98.57%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.33
0.10
0.23
230.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
49.03
25.90
23.13
89.31%
Equity Capital
8.57
10.42
-1.85
-17.75%
Face Value
10.00
2.00
0.00
Reserves
262.44
0.00
262.44
Gross Profit Margin
59.69%
28.28%
0.00
31.41%
PAT Margin
47.07%
11.02%
0.00
36.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 106.49 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 43.96% vs 44.67% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 49.03 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 25.17% vs 64.17% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 48.29 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 14.46% vs 82.64% in Dec 2024
Nine Monthly - Interest
Interest 0.14 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 133.33% vs -25.00% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.35%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024






